Mid-Atlantic BioTherapeutics: Funding, Investors & Team (Oct 2026)
Mid-Atlantic BioTherapeutics is concentrating on the advancement and marketing of a new immunotherapy for infectious diseases, aiming to combat antibiotic resistance and develop innovative treatments for viral diseases, emerging infections, and biodefense.
Mid-Atlantic BioTherapeutics has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Jun 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mid-Atlantic BioTherapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Mid-Atlantic BioTherapeutics Funding Rounds
Mid-Atlantic BioTherapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Mid-Atlantic BioTherapeutics Funding Compared to Other Biotechnology Startups
Mid-Atlantic BioTherapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mid-Atlantic BioTherapeutics in Biotechnology and Doylestown
Companies Similar to Mid-Atlantic BioTherapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Mid-Atlantic BioTherapeutics Funding FAQs
What does Mid-Atlantic BioTherapeutics do?
Mid-Atlantic BioTherapeutics is concentrating on the advancement and marketing of a new immunotherapy for infectious diseases, aiming to combat antibiotic resistance and develop innovative treatments for viral diseases, emerging infections, and biodefense.
How much funding has Mid-Atlantic BioTherapeutics raised?
Mid-Atlantic BioTherapeutics has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Jun 2024.
When did Mid-Atlantic BioTherapeutics last raise funding?
Mid-Atlantic BioTherapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Jun 2024.
Who founded Mid-Atlantic BioTherapeutics?
FundedIQ lists David Jobes (Founder) at Mid-Atlantic BioTherapeutics.
Where is Mid-Atlantic BioTherapeutics headquartered?
Mid-Atlantic BioTherapeutics is based in Doylestown, Pennsylvania, United States.
How many employees does Mid-Atlantic BioTherapeutics have?
Mid-Atlantic BioTherapeutics is in the 1-10 employee band.
How does Mid-Atlantic BioTherapeutics' funding compare to other Biotechnology startups?
Mid-Atlantic BioTherapeutics' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mid-Atlantic BioTherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mid-Atlantic BioTherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.